Not Signed In -
Fluticasone Inhalation Aerosol |
Flovent |
Fluticasone Systematic (IUPAC) name 6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17- (1-oxopropoxy)-androsta-1,4-diene-17-carbothioic acid (6α,11β,16α,17α)- S-(fluoromethyl) ester Identifiers CAS number 80474-14-2 ATC code D07AC17 R01AD08, R03BA05 PubChem 444036 DrugBank APRD00065 Chemical data Formula C25H31F3O5S Mol. weight 500.572 g/mol Pharmacokinetic data Bioavailability 0.51% (Intranasal) Protein binding 91% Metabolism Intranasal- hepatic cytochrome p4 ...
Wikipedia - [full article]
Fluticasone Inhalation Aerosol Clinical Trials
- Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent? Inhalation Aerosol in COPD Patients.
ClinicalTrials.gov Identifier: NCT00388882 - Active, not recruiting
Pulmonary Disease, Chronic Obstructive
- A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent? Inhalation Aerosol in COPD Patients.
ClinicalTrials.gov Identifier: NCT00359788 - Recruiting
Pulmonary Disease, Chronic Obstructive
- A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects with Persistent Asthma
ClinicalTrials.gov Identifier: NCT00116103 - Completed
Asthma
- A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Sallmeterol Inhalation Aerosol.
ClinicalTrials.gov Identifier: NCT00274560 - Completed
Pulmonary Disease, Chronic Obstructive
- Comparator Study Evaluating Patient Preference Of Fluticasone Furoate Nasal Spray vs. Fluticasone Propionate Nasal Spray
ClinicalTrials.gov Identifier: NCT00539006 - Active, not recruiting
Seasonal Allergic Rhinitis
- A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 HFA Versus Fluticasone Propionate 100 HFA In Children With Asthma
ClinicalTrials.gov Identifier: NCT00441441 - Active, not recruiting
Asthma
- Study of Asthma in Patients of African Descent
ClinicalTrials.gov Identifier: NCT00102765 - Active, not recruiting
Asthma
- The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial (The LOCCS Trial)
ClinicalTrials.gov Identifier: NCT00156819 - Active, not recruiting
Asthma
- A Study Measuring Asthma Control in Pediatric and Adolescent Subjects Whose Asthma is Worsened by Activity Or Exercise
ClinicalTrials.gov Identifier: NCT00118690 - Active, not recruiting
Bronchospasm; Asthma, Exercise-Induced
- Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis
ClinicalTrials.gov Identifier: NCT00123656 - Recruiting
Esophagitis
- Asthma Control in Pediatric and Adolescent Subjects Whose Asthma is Worsened by Activity Or Exercise
ClinicalTrials.gov Identifier: NCT00118716 - Active, not recruiting
Bronchospasm; Asthma, Exercise-Induced
- Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood
ClinicalTrials.gov Identifier: NCT00116311 - Active, not recruiting
Asthma; Healthy
- A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg Twice Daily In Symptomatic Patients With Asthma
ClinicalTrials.gov Identifier: NCT00452348 - Recruiting
Asthma
- A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg BID In Symptomatic Subjects With Asthma
ClinicalTrials.gov Identifier: NCT00452699 - Recruiting
Asthma
- Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
ClinicalTrials.gov Identifier: NCT00144846 - Recruiting
acute wheezing obstructive airways disease
- NO Donors and Inhibitors Study
ClinicalTrials.gov Identifier: NCT00159380 - Recruiting
Asthma; Healthy volunteers
- Safety Study of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients with P. Aeruginosa
ClinicalTrials.gov Identifier: NCT00128492 - Active, not recruiting
Cystic Fibrosis
- Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis
ClinicalTrials.gov Identifier: NCT00388505 - Recruiting
Cystic Fibrosis
- Fluticasone Nasal Spray Patient Preference Study
ClinicalTrials.gov Identifier: NCT00398476 - Active, not recruiting
Allergic Rhinitis
- A Pilot Study of the Mechanism of Synergism between Fluticasone (FP) and Salmeterol in Preventing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
ClinicalTrials.gov Identifier: NCT00116402 - Recruiting
Pulmonary Disease, Chronic Obstructive
- Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
ClinicalTrials.gov Identifier: NCT00435461 - Active, not recruiting
Hayfever; Allergic Rhinitis
- The Effects of Nitric Oxide for Inhalation During Left Ventricular Assists Device (LVAD) Implantation
ClinicalTrials.gov Identifier: NCT00060840 - Recruiting
Congestive Heart Failure
- A Six-Week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in COPD
ClinicalTrials.gov Identifier: NCT00239421 - Active, not recruiting
Pulmonary Disease, Chronic Obstructive
- Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With Asthma
ClinicalTrials.gov Identifier: NCT00238927 - Active, not recruiting
Asthma
- Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)
ClinicalTrials.gov Identifier: NCT00480649 - Active, not recruiting
Asthma
- Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (Study P04139)
ClinicalTrials.gov Identifier: NCT00379288 - Active, not recruiting
Asthma
- Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma
ClinicalTrials.gov Identifier: NCT00394199 - Active, not recruiting
Asthma
- Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422)
ClinicalTrials.gov Identifier: NCT00458835 - Active, not recruiting
Allergic Rhinitis
- Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
ClinicalTrials.gov Identifier: NCT00502775 - Recruiting
Allergic Rhinitis; Hay Fever
- Staccato® Prochlorperazine for Inhalation in Migraine
ClinicalTrials.gov Identifier: NCT00422812 - Active, not recruiting
Migraine Headache; Aura
- Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma
ClinicalTrials.gov Identifier: NCT00232648 - Active, not recruiting
Asthma
- A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.
ClinicalTrials.gov Identifier: NCT00274534 - Completed
Pulmonary Disease, Chronic Obstructive
- Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics
ClinicalTrials.gov Identifier: NCT00364442 - Completed
Asthma
- Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.
ClinicalTrials.gov Identifier: NCT00570492 - Recruiting
Perennial Allergic Rhinitis
- Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418AM4)
ClinicalTrials.gov Identifier: NCT00394355 - Recruiting
Asthma
- Does Inhaled Busedonide or Fluticasone Impair Adrenal Function?
ClinicalTrials.gov Identifier: NCT00560625 - Recruiting
Adrenal Insufficency
- Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease
ClinicalTrials.gov Identifier: NCT00357279 - Active, not recruiting
Cystic Fibrosis
- Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00325364 - Active, not recruiting
Diabetes Mellitus, Type 2
- A Pilot Study of Aerosol Interferon-Gamma for Treatment of Idiopathic Pulmonary Fibrosis
ClinicalTrials.gov Identifier: NCT00563212 - Recruiting
Pulmonary Fibrosis
- A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males
ClinicalTrials.gov Identifier: NCT00475371 - Active, not recruiting
Diabetes Mellitus, Type 2; Healthy Males
- Aerosol L9-NC and Temozolomide in Ewing's Sarcoma
ClinicalTrials.gov Identifier: NCT00492141 - Recruiting
Ewing's Sarcoma; Lung Cancer
- Study of Dust Mite Inhalation in Humans
ClinicalTrials.gov Identifier: NCT00448851 - Recruiting
Mild Asthma; Allergy
- Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma
ClinicalTrials.gov Identifier: NCT00497237 - Recruiting
Asthma
- Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPD
ClinicalTrials.gov Identifier: NCT00530842 - Recruiting
Pulmonary Disease, Chronic Obstructive
- Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma
ClinicalTrials.gov Identifier: NCT00393991 - Recruiting
Asthma
- Responsiveness of Lower Airways in Adult Patients (18-60 y) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)
ClinicalTrials.gov Identifier: NCT00306163 - Recruiting
Asthma
- Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects
ClinicalTrials.gov Identifier: NCT00517634 - Not yet recruiting
Asthma
- 4-Dimensional CT Derived Ventilation Versus SPECT Aerosol Ventilation in Patients With Lung Cancer
ClinicalTrials.gov Identifier: NCT00531180 - Recruiting
Lung Cancer
- Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles on Airway Inflammation in Asthmatics
ClinicalTrials.gov Identifier: NCT00527462 - Recruiting
Asthma
- Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00332488 - Active, not recruiting
Diabetes Mellitus, Type 2
- New Combination Inhaler (Flutiform HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma
ClinicalTrials.gov Identifier: NCT00393952 - Recruiting
Asthma
- Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
ClinicalTrials.gov Identifier: NCT00265434 - Active, not recruiting
Cystic Fibrosis; Chronic Rhinosinusitis
- Staccato® Loxapine for Inhalation in Patients With Migraine Headache
ClinicalTrials.gov Identifier: NCT00489476 - Recruiting
Migraine
- Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients with Non-Small-Cell Lung Carcinoma (NSCLC)
ClinicalTrials.gov Identifier: NCT00082472 - Active, not recruiting
NSCLC
- An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-Severe Persistent, Reversible Asthma
ClinicalTrials.gov Identifier: NCT00563056 - Recruiting
Asthma Bronchiale
- The Effect of Fluticasone/Salmeterol Combination on Exertional Breathlessness in Patients With Mild COPD
ClinicalTrials.gov Identifier: NCT00559312 - Not yet recruiting
COPD
- Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung Disease
ClinicalTrials.gov Identifier: NCT00425165 - Recruiting
Cystic Fibrosis
- Effects of Acetazolamide and CO2 Inhalation on Exercise-Induced Periodic Breathing in Heart Failure
ClinicalTrials.gov Identifier: NCT00517426 - Recruiting
Chronic Heart Failure
- Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies
ClinicalTrials.gov Identifier: NCT00551642 - Recruiting
Lung Disease
- The “VISION” Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension
ClinicalTrials.gov Identifier: NCT00302211 - Recruiting
Pulmonary Hypertension
- A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial Assessing the Rate of Decline of Lung Function with Tiotropium (Spiriva®) 18 Mcg Inhalation Capsule Once Daily in Patients with Chronic Obstructive Pulmonary Disaese (COPD).
ClinicalTrials.gov Identifier: NCT00144339 - Active, not recruiting
Pulmonary Disease, Chronic Obstructive
- Multidose Safety and Tolerability Study of (Arikace™) for Inhalation In Cystic Fibrosis Patients
ClinicalTrials.gov Identifier: NCT00558844 - Recruiting
Cystic Fibrosis
- Efficacy of Tiotropium in Patients of African Descent with Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov Identifier: NCT00106821 - Active, not recruiting
Chronic Obstructive Pulmonary Disease
- Influence Of Salmeterol/Fluticasone (50/500BD)On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV
ClinicalTrials.gov Identifier: NCT00527826 - Not yet recruiting
COPD
- Budesonide Inhalation Suspension for Acute Asthma in Children
ClinicalTrials.gov Identifier: NCT00393367 - Recruiting
Asthma; Acute Asthma; Reactive Airway Exacerbation
- Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome
ClinicalTrials.gov Identifier: NCT00378677 - Recruiting
Lung Transplantation; Bronchiolitis Obliterans
- Dose-Ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis
ClinicalTrials.gov Identifier: NCT00504426 - Recruiting
Pain Due to Osteoporosis
- Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis
ClinicalTrials.gov Identifier: NCT00547053 - Recruiting
Cystic Fibrosis
- Staccato™ Alprazolam for Inhalation in Panic Attack
ClinicalTrials.gov Identifier: NCT00477451 - Recruiting
Panic Attack
- Nasal Inhalation of Pulmozyme in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
ClinicalTrials.gov Identifier: NCT00534079 - Recruiting
Cystic Fibrosis; Rhinosinusitis
- The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc 15 Setting
ClinicalTrials.gov Identifier: NCT00467896 - Recruiting
Pulmonary Hypertension
- Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov Identifier: NCT00523991 - Recruiting
Pulmonary Disease, Chronic Obstructive
- A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children with Cystic Fibrosis
ClinicalTrials.gov Identifier: NCT00006280 - Completed
Cystic Fibrosis
- The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis
ClinicalTrials.gov Identifier: NCT00119015 - Recruiting
Rhinitis, Allergic, Perennial
- Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol Inhalation
ClinicalTrials.gov Identifier: NCT00162487 - Recruiting
Hyperkalemia; Chronic Renal Failure
- Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up
ClinicalTrials.gov Identifier: NCT00309244 - Recruiting
Diabetes Mellitus, Type 2
- Inhalation SLIT Cisplatin for the Treatment of Osteosarcoma Metastatic to the Lung
ClinicalTrials.gov Identifier: NCT00102531 - Recruiting
Osteosarcoma
- Pediatric Asthma Study Using Stepwise Treatment With Two FDA Approved Asthma Medications
ClinicalTrials.gov Identifier: NCT00158834 - Completed
Children aged 6-16 year, with moderate/ severe asthma using inhaled steroids.
- Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises
ClinicalTrials.gov Identifier: NCT00094887 - Recruiting
Anemia, Sickle Cell
- Safety and Efficacy Study of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients with P. aeruginosa
ClinicalTrials.gov Identifier: NCT00104520 - Completed
Cystic Fibrosis
- International Safety and Efficacy Study of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients
ClinicalTrials.gov Identifier: NCT00112359 - Completed
Cystic Fibrosis
- Effect of Age and Device on Delivery of Fluticasone
ClinicalTrials.gov Identifier: NCT00308932 - Completed
Asthma
- Preprocedural Fasting and Nitrous Oxide -Oxygen Inhalation Analgesia for Dental Treatment of Children
ClinicalTrials.gov Identifier: NCT00263289 - Not yet recruiting
Vomiting
- A 12-Week Randomised, Double Blind, Placebo Controlled, Parallel Group Trial Evaluating the Efficacy and Safety of Inhaled Tiotropium 18µg q.d. in Patients with COPD and a Concomitant Diagnosis of Asthma
ClinicalTrials.gov Identifier: NCT00152984 - Completed
Pulmonary Disease, Chronic Obstructive; Asthma
- Randomized Trial of Fluticasone in Bronchial Premalignancy
ClinicalTrials.gov Identifier: NCT00407264 - Completed
Bronchogenic Carcinoma
- Advair DISKUS® (Fluticasone Propionate/Salmeterol) Versus Serevent® DISKUS (Salmeterol) for Chronic Obstructive Pulmonary Disease Exacerbations
ClinicalTrials.gov Identifier: NCT00115492 - Completed
Chronic Obstructive Pulmonary Disease
- Dornase Alfa Inhalation Solution or a Placebo in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Radiation Therapy and Chemotherapy
ClinicalTrials.gov Identifier: NCT00536952 - Not yet recruiting
Head and Neck Cancer
- Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone Propionate
ClinicalTrials.gov Identifier: NCT00400855 - Completed
Asthma
- Aerosol Cyclosporine for Prevention of Lung Rejection
ClinicalTrials.gov Identifier: NCT00268515 - Completed
Lung Diseases
- Advair® DISKUS® (Fluticasone Propionate/Salmeterol) Versus Serevent® DISKUS® (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations
ClinicalTrials.gov Identifier: NCT00144911 - Completed
Chronic Obstructive Pulmonary Disease
- Endotoxin and Inflammatory Markers
ClinicalTrials.gov Identifier: NCT00159289 - Recruiting
Mild to moderate Chronic Obstructive Pulmonary Disease (COPD); Volunteers (healthy non-smokers); Volunteers (current or ex-smokers)
- Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in COPD
ClinicalTrials.gov Identifier: NCT00239499 - Completed
Pulmonary Disease, Chronic Obstructive
- A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients
ClinicalTrials.gov Identifier: NCT00453778 - Completed
Mild Asthma
- Efficacy and Safety of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects
ClinicalTrials.gov Identifier: NCT00125346 - Suspended
Cystic Fibrosis
- Staccato® Alprazolam for Inhalation in Panic Disorder
ClinicalTrials.gov Identifier: NCT00444522 - Completed
Healthy
- Airway Hyper-Responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product
ClinicalTrials.gov Identifier: NCT00291382 - Completed
Asthma
- A Pilot Study of Aerosol Interferon-Gamma Treatment in Pulmonary Fibrosis
ClinicalTrials.gov Identifier: NCT00212563 - Completed
Idiopathic Pulmonary Fibrosis
- The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Inflammometry
ClinicalTrials.gov Identifier: NCT00402207 - Completed
Asthma
- StaccatoTM Loxapine for Inhalation in Schizophrenic Patients With Agitation.
ClinicalTrials.gov Identifier: NCT00369577 - Completed
Schizophrenia
- Staccato® Fentanyl for Inhalation in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00402350 - Completed
Breakthrough Pain
Resources
- Flovent (Drug Digest)
- Fluticasone Inhalation Aerosol (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
